FindMyRecallSubscribe
Class I: serious health riskTerminated

Greenstone Venlafaxine HCl Extended-Release Capsules Recall

Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx onl…

Greenstone Llc · Peapack, NJ

Risk level
Class I
Reported by FDA
Jun 18, 2014
Recall ID
D-1361-2014
Check your lot numberHow we source this data

Summary

Greenstone recalled Venlafaxine HCl Extended-Release Capsules starting Mar 6, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-1361-2014 on Jun 18, 2014. Reason: Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot

Product description

Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0182-2, UPC 3 59762-0182-2 9.

Lot numbers, UPCs & expiration codes

V130014, Exp 08/15

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1361-2014
Classification
Class I
Status
Terminated
Recall initiated
Mar 6, 2014
FDA report date
Jun 18, 2014
Quantity
16,018 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Greenstone Llc

Original FDA data

Every field from FDA enforcement report D-1361-2014, exactly as published.

Show all FDA fields
City
Peapack
State
NJ
Status
Terminated
Country
United States
Event ID
67637
Address
100 Route 206 North
Code information
V130014, Exp 08/15
Postal code
07977
Report date
Jun 18, 2014
Product type
Drugs
Recall number
D-1361-2014
Classification
Class I
Recalling firm
Greenstone Llc
Product quantity
16,018 bottles
Termination date
May 10, 2017
Reason for recall
Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot
Voluntary / mandated
Voluntary: Firm initiated
Product description
Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0182-2, UPC 3 59762-0182-2 9.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 6, 2014
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jun 9, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1361-2014, published Jun 18, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls